FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment | HIV.gov

FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment | HIV.gov

FDA Approves First Two-drug Complete Regimen for HIV-infected Patients Who Have Never Received Antiretroviral Treatment

This week, the U.S. Food and Drug Administration approved Dovato, the first two-drug (dolutegravir and lamivudine), fixed-dose, complete regimen for adults living with HIV who have never received treatment for HIV...

LEARN MORE